Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-20-006768
Filing Date
2020-07-07
Accepted
2020-07-07 17:11:11
Documents
9

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 78476
2 filename2.htm EX-10.7 1324200
3 filename3.htm EX-10.8 173961
4 filename4.htm EX-10.9 103091
5 filename5.htm EX-10.10 216672
6 filename6.htm EX-10.11 253613
7 filename7.htm EX-10.12 14741
8 GRAPHIC g904148g16j92.jpg GRAPHIC 4486
9 GRAPHIC g904148g49u55.jpg GRAPHIC 15170
  Complete submission text file 0000950123-20-006768.txt   2193146
Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Filer) CIK: 0001651431 (see all company filings)

EIN.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-03169 | Film No.: 201016629
SIC: 2836 Biological Products, (No Diagnostic Substances)